CN106344818A - 一种用于治疗偏头痛的中药组合物的制备方法 - Google Patents
一种用于治疗偏头痛的中药组合物的制备方法 Download PDFInfo
- Publication number
- CN106344818A CN106344818A CN201610975254.4A CN201610975254A CN106344818A CN 106344818 A CN106344818 A CN 106344818A CN 201610975254 A CN201610975254 A CN 201610975254A CN 106344818 A CN106344818 A CN 106344818A
- Authority
- CN
- China
- Prior art keywords
- parts
- decocting
- chinese medicine
- medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 71
- 239000000203 mixture Substances 0.000 title claims abstract description 17
- 238000000034 method Methods 0.000 title claims abstract description 12
- 208000019695 Migraine disease Diseases 0.000 title abstract description 12
- 206010027599 migraine Diseases 0.000 title abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 239000007788 liquid Substances 0.000 claims abstract description 18
- 229940079593 drug Drugs 0.000 claims abstract description 10
- 210000000582 semen Anatomy 0.000 claims abstract description 10
- 238000009835 boiling Methods 0.000 claims abstract description 8
- 238000002791 soaking Methods 0.000 claims abstract description 6
- 241000628997 Flos Species 0.000 claims description 17
- 238000002360 preparation method Methods 0.000 claims description 15
- 239000009636 Huang Qi Substances 0.000 claims description 9
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 9
- 238000007654 immersion Methods 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 6
- 210000003298 dental enamel Anatomy 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 2
- 239000010935 stainless steel Substances 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract 3
- JEGUKCSWCFPDGT-UHFFFAOYSA-N h2o hydrate Chemical compound O.O JEGUKCSWCFPDGT-UHFFFAOYSA-N 0.000 abstract 2
- 239000008213 purified water Substances 0.000 abstract 2
- 240000000559 Albizia odoratissima Species 0.000 abstract 1
- 235000011438 Albizia odoratissima Nutrition 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 241000305491 Gastrodia elata Species 0.000 abstract 1
- 235000019082 Osmanthus Nutrition 0.000 abstract 1
- 241000333181 Osmanthus Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 241001180876 Saposhnikovia Species 0.000 abstract 1
- 239000010975 amethyst Substances 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 238000005303 weighing Methods 0.000 abstract 1
- 206010019233 Headaches Diseases 0.000 description 16
- 231100000869 headache Toxicity 0.000 description 16
- 208000002193 Pain Diseases 0.000 description 11
- 230000036407 pain Effects 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- -1 absorption carrier Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007919 dispersible tablet Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000000541 pulsatile effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于治疗偏头痛的中药组合物的制备方法,包括以下步骤:(1)以重量份表示,称取天麻1~10份、白芷1~10份、茯苓1~10份、黄芪1~10份、赤芍1~10份、桂花1~10份、合欢花1~10份、橘核1~10份、紫石英1~15份、酸枣仁1~10份、枇杷叶1~10份、细辛1~10份、独活1~10份、鸡血藤1~10份、防风1~10份;(2)将上述全部中药原料药,先行用清水或纯净水浸泡60分钟,浸泡用水量为0.9~1.1L;(3)将浸泡后的中药原料药物及其浸泡的药水加入到煎药容器中,加盖共同煎熬;(4)先用武火使煎药容器中药液沸腾,再使用文火熬制30~60分钟,煎药时需搅拌2~3次;(5)煎煮完成后,加适量清水或纯净水没过药物,进行第二次煎煮,煎煮火候方法同上,煎煮时间30~60分钟。
Description
技术领域
本发明属于中医药领域,具体是指一种用于治疗偏头痛的中药组合物的制备方法。
背景技术
偏头痛是一种发生在头部或左或右、是以头痛暴作、疼痛剧烈、反复发作为特征的搏动性头痛。发作前常有先兆,如眼前闪光、视物模糊、肢体麻木等,可伴恶心、呕吐,安静、黑暗环境内或睡眠后头痛缓解,反复发作特征相似。本病属中医学“头痛”、“头风”、“偏头痛”、“偏头风”等范畴。
欧美国家患病率为1500~2000/10万人口(1.5%~2%)。中国患病率为732.1/10万人口(0.73%),发病率65.8/10万人口(0.06%)。国外患病年龄以25~45岁多见,45%病人在儿童和青春期起病,但1~12岁儿童不少见,首次发病<10岁占25%。男孩发病年龄小于女孩。中国患病年龄以20~45岁多见,10岁以下仅42.6/10万人口,14岁以下仅182/10万人口。国外女性较男性多2~3倍。中国患病率男性392.8/10万人口,女性1579.2/10万人口。
目前西医只能靠止痛药来缓解疼痛,并无特效药物,而吃止痛药,往往初期有效,吃久了止不住疼痛,或者加大药量,药物的副作用也会随之出现,常见的有胃炎、胃出血、胃溃疡、解热镇痛性肾炎等,甚至会引起药物性头痛。可以说,对于偏头疼,现代西医没有办法治愈。
发明内容
本发明的目的是克服传统药物的缺陷,提供一种疗效显著,质量容易控制,稳定性好的用于治疗偏头痛的中药组合物的制备方法。
本发明通过下述技术方案实现:一种用于治疗偏头痛的中药组合物的制备方法,其特征在于,包括以下步骤:
(1)以重量份表示,称取天麻1~10份、白芷1~10份、茯苓1~10份、黄芪1~10份、赤芍1~10份、桂花1~10份、合欢花1~10份、橘核1~10份、紫石英1~15份、酸枣仁1~10份、枇杷叶1~10份、细辛1~10份、独活1~10份、鸡血藤1~10份、防风1~10份;
(2)将上述全部中药原料药,先行用清水或纯净水浸泡60-120分钟,浸泡用水量为0.5~2.1L;
(3)将浸泡后的中药原料药物及其浸泡的药水加入到煎药容器中,加盖共同煎熬;
(4)先用武火使煎药容器中药液沸腾,再使用文火熬制30~150分钟,煎药时需搅拌2~10次;
(5)煎煮完成后,加适量清水或纯净水没过药物,进行第二次煎煮,煎煮火候方法同上,煎煮时间30~150分钟;
(6)滤出药液,所获药液即为内服药物。
本发明治疗偏头痛的中药组合物可以为片剂、分散片、颗粒剂、胶囊剂或
汤剂。
本发明治疗偏头痛的中药组合物中一份的量2~5g,优选一份的量3g。
在药剂制备过程中根据需要,可以加入各种药学上可接受的载体。所述的载体包括药学领域常规的稀释剂、赋形剂、填充剂、粘合剂、湿润剂、崩解剂、吸收促进剂、表面活性剂、吸附载体、润滑剂等。本发明的药剂在制备时,可选择的填充剂有:淀粉、糖粉、磷酸钙、糊精、微晶纤维素、乳糖、预胶化淀粉、甘露醇等;可选择的粘合剂有:羧甲基纤维素钠、PVP-K30、羟丙基纤维素、淀粉浆、甲基纤维素、乙基纤维素、羟丙基甲基纤维素、胶化淀粉等;可选择的崩解剂有:干淀粉、交联聚维酮、交联羧甲基纤维素钠、羧甲基淀粉钠、低取代羟丙基纤维素等;可选择的润滑剂有:硬脂酸镁、滑石粉、十二烷基硫酸钠、微粉硅胶等。
为更好实现本发明的方法,进一步确定所述煎药容器为砂锅、搪瓷或者不锈钢器皿,尤其忌用铁器。
为更好实现本发明的方法,进一步确定煎煮三次包括第一次加10倍量的水煎煮2小时,第二次加8倍量的水煎煮1小时,第三次加6倍量的水煎煮1小时。
为更好实现本发明的发明,进一步确定在所述步骤(1)中先行用先行用清水或纯净水浸泡90-100分钟,浸泡用水量为1.0~1.5L;
为更好实现本发明的发明,进一步确定在所述步骤(4)中先用武火使煎药容器中药液沸腾,再使用文火熬制60~90分钟,煎药时需搅拌2~5次。
本发明所述的一种用于治疗偏头痛的中药组合物的原料药药理:
天麻:性甘,平。归肝经,平肝息风止痉,用于头痛。用于头痛眩晕,肢体麻木,小儿惊风,癫痫抽搐,破伤风。
白芷:性温。归胃、大肠、肺经。散风除湿,通窍止痛,消肿排脓。用于感冒头痛,眉棱骨痛,鼻塞,鼻渊,牙痛,白带,疮疡肿痛。
茯苓:性甘、淡,平。归心、肺、脾、肾经。利水渗湿,健脾宁心。用于水肿尿少,痰饮眩悸,脾虚食少,便溏泄泻,心神不安,惊悸失眠。
黄芪:性甘,温。归肺、脾经。补气固表,利尿托毒,排脓,敛疮生肌。用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿,内热消渴等。
赤芍:性苦,微寒。归肝经。清热凉血,散瘀止痛。用于温毒发斑,吐血衄血,目赤肿痛,肝郁胁痛,经闭痛经,症瘕腹痛,跌扑损伤,痈肿疮疡。
桂花:性辛,温。散寒破结,化痰止咳。用于牙痛,咳喘痰多,经闭腹痛。
合欢花:性味甘,平。舒郁、理气、安神、活络、养血、滋阴肾、清心明目。
橘核:性平、味苦。归肝、肾经。理气,散结,止痛。
紫石英:性甘,温。入心、肝经。镇心,安神,降逆气。
酸枣仁:性甘,平。归心经,脾经。肝经;胆经。宁心安神;养肝;敛汗。
枇杷叶:性苦,微寒。归肺,胃经。疏肝理气。细辛:性辛,温。归心、肺、肾经。解表散寒,祛风止痛,通窍,温肺化饮。
独活:性味辛、苦,性微温。归肾、膀胱经。祛风除湿,痛痹止痛。
鸡血藤:性温。归肝、心、肾经。活血舒筋。
防风:性味辛、甘,性微温。归膀胱、肺、脾、肝经。祛风解表,胜湿止痛,止痉。
本发明与现有技术相比,具有的优点及有益效果为:
本发明是基于对偏头痛症状机理的认识及治疗原则,采用直接口服的方法,攻补兼施,共具有镇痛、安神的效果,疗效显著,质量容易控制,稳定性好,基本无不良反应,易于吸收、见效快、使用方便、价格低。
具体实施方式
下面结合实施例对本发明作进一步地详细说明,但本发明的实施方式不限于此,在不脱离本发明上述技术思想情况下,根据本领域普通技术知识和惯用手段,做出各种替换和变更,均应包括在本发明的范围内。
实施例1:
本实施例所述用于治疗偏头痛的中药组合物,以重量份表示,所述内服药物组分主要由天麻、白芷、茯苓、黄芪、赤芍、桂花、合欢花、橘核、紫石英、酸枣仁、枇杷叶、细辛、独活、鸡血藤、防风组成;
本发明药物的制备方法,包括以下步骤:
(1)以重量份表示,称取天麻5份、白芷3份、茯苓2份、黄芪4份、赤芍5份、桂花1份、合欢花2份、橘核8份、紫石英1份、酸枣仁3份、枇杷叶2份、细辛3份、独活2份、鸡血藤4份、防风3份;
(2)将上述全部中药原料药,先行用清水或纯净水浸泡60-120分钟,浸泡用水量为0.5~2.1L;
(3)将浸泡后的中药原料药物及其浸泡的药水加入到煎药容器中,加盖共同煎熬;
(4)先用武火使煎药容器中药液沸腾,再使用文火熬制30~150分钟,煎药时需搅拌2~10次;
(5)煎煮完成后,加适量清水或纯净水没过药物,进行第二次煎煮,煎煮火候方法同上,煎煮时间30~150分钟;
(6)滤出药液,所获药液即为内服药物。
本发明治疗偏头痛的中药组合物中一份的量2~5g,优选一份的量3g。
上述煎药容器为砂锅、搪瓷或者不锈钢器皿,尤其忌用铁器。
本发明药物的使用方法:直接内服。
实施例2:
在上述实施例中进一步确定本发明药物的制备方法,共煎煮三次,包括第一次加10倍量的水煎煮2小时,第二次加8倍量的水煎煮1小时,第三次加6倍量的水煎煮1小时。
实施例3:
在上述实施例中进一步确定本发明药物的制备方法,在所述步骤(2)中先行用清水或纯净水浸泡90-100分钟,浸泡用水量为1.0~1.5L。
实施例4:
本上述实施例中进一步确定本发明药物的制备方法,在所述步骤(4)中先用武火使煎药容器中药液沸腾,再使用文火熬制60~90分钟,煎药时需搅拌2~5次。
实施例5:
本实施例所述重要偏头痛内服药物,以重量份表示,所述天麻7份、白芷2份、茯苓3份、黄芪4份、赤芍5份,桂花6份、合欢花3份,橘核2份、紫石英6份、酸枣仁3份、枇杷叶4份、细辛5份、独活7份、鸡血藤7份、防风5份。
实施例6:
本实施例所述重要偏头痛内服药物,以重量份表示,所述天麻4份、白芷5份、茯苓4份、黄芪6份、赤芍7份,桂花6份、合欢花2份,橘核2份、紫石英7份、酸枣仁5份、枇杷叶5份、细辛5份、独活6份、鸡血5份、防风7份。
实施例7:
本实施例所述重要偏头痛内服药物,以重量份表示,所述天麻5份、白芷7份、茯苓4份、黄芪7份、赤芍4份,桂花6份、合欢花3份,橘核3份、紫石英6份、酸枣仁2份、枇杷叶6份、细辛7份、独活6份、鸡血藤5份、防风3份。
实施例8:
本实施例所述重要偏头痛内服药物,以重量份表示,所述天麻36份、白芷8份、茯苓4份、黄芪9份、赤芍8份,桂花6份、合欢花1份,橘核2份、紫石英5份、酸枣仁5份、枇杷叶5份、细辛8份、独活8份、鸡血藤7份、防风6份。
利用本发明药物针对各种偏头痛患者的临床统计资料:
经过300例患者的临床使用,其中男患者163,女患者137例,用药年龄对象20~60岁。其中最小21岁,最大59岁,平均年龄38岁;轻度偏头痛121例,中度偏头痛141例,重度偏头痛38例。
典型病例:
1、蔡某,女,61岁,浙江杭州人,头痛7年,加重2天,双太阳穴及后头部疼痛,伴有头晕,无恶心呕吐,舌体大,质红,苔白,脉弦,服用第2个疗程后,头痛、头晕减轻,汗多,舌体大,质暗,苔白,脉沉弦,继续服用第4个疗程后,头痛基本消失,头晕明显减轻,舌体大,质红暗,苔白腻,脉沉弦,继续服用第5个疗程后,症状消失,随访,至今未复发。
2、房某,男,46岁,吉林白城人,头痛5年,患者自诉左侧太阳穴为主,跳痛,睡眠差可诱发,每月疼2~3次,持续性,面热,舌质暗,体大,苔白,脉弦。服用1个疗程后,头痛未发,时有面热,睡眠亦有好转,舌质暗,苔白,脉弦。继续服用1个疗程后,头痛1个月中仅发作1次,较轻,舌质暗,体略大,苔白,脉弦。继续服用1个疗程后,头痛消失,时有面热,舌体大,质红暗,苔白,脉弦滑。3个月后电话随访,头痛再无发作。
以上所述,仅是本发明的较佳实施例,并非对本发明做任何形式上的限制,凡是依据本发明的技术实质对以上实施例所作的任何简单修改、等同变化,均落入本发明的保护范围之内。
Claims (5)
1.一种用于治疗偏头痛的中药组合物的制备方法,其特征在于,包括以下步骤:
(1)以重量份表示,称取天麻1~10份、白芷1~10份、茯苓1~10份、黄芪1~10份、赤芍1~10份、桂花1~10份、合欢花1~10份、橘核1~10份、紫石英1~15份、酸枣仁1~10份、枇杷叶1~10份、细辛1~10份、独活1~10份、鸡血藤1~10份、防风1~10份;
(2)将上述全部中药原料药,先行用清水或纯净水浸泡60-120分钟,浸泡用水量为0.5~2.1L;
(3)将浸泡后的中药原料药物及其浸泡的药水加入到煎药容器中,加盖共同煎熬;
(4)先用武火使煎药容器中药液沸腾,再使用文火熬制30~150分钟,煎药时需搅拌2~10次;
(5)煎煮完成后,加适量清水或纯净水没过药物,进行第二次煎煮,煎煮火候方法同上,煎煮时间30~150分钟;
(6)滤出药液,所获药液即为内服药物。
2.根据权利要求1所述的一种用于治疗偏头痛的中药组合物的制备方法,其特征在于,所述煎药容器为砂锅、搪瓷或者不锈钢器皿。
3.根据权利要求1所述的一种用于治疗偏头痛的中药组合物的制备方法,其特征在于,煎煮三次包括第一次加10倍量的水煎煮2小时,第二次加8倍量的水煎煮1小时,第三次加6倍量的水煎煮1小时。
4.根据权利要求1所述的一种用于治疗偏头痛的中药组合物的制备方法,其特征在于,在所述步骤(2)中先行用先行用清水或纯净水浸泡90-100分钟,浸泡用水量为1.0~1.5L。
5.根据权利要求1所述的一种用于治疗偏头痛的中药组合物的制备方法,其特征在于,在所述步骤(4)中先用武火使煎药容器中药液沸腾,再使用文火熬制60~90分钟,煎药时需搅拌2~5次。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610975254.4A CN106344818A (zh) | 2016-11-07 | 2016-11-07 | 一种用于治疗偏头痛的中药组合物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610975254.4A CN106344818A (zh) | 2016-11-07 | 2016-11-07 | 一种用于治疗偏头痛的中药组合物的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106344818A true CN106344818A (zh) | 2017-01-25 |
Family
ID=57865248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610975254.4A Withdrawn CN106344818A (zh) | 2016-11-07 | 2016-11-07 | 一种用于治疗偏头痛的中药组合物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106344818A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107213170A (zh) * | 2017-06-27 | 2017-09-29 | 青川县川申农特产开发有限公司 | 一种桂花蜂蜜及制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104147388A (zh) * | 2014-08-25 | 2014-11-19 | 唐国萍 | 一种治疗偏头疼的中药组合物及其制备方法 |
-
2016
- 2016-11-07 CN CN201610975254.4A patent/CN106344818A/zh not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104147388A (zh) * | 2014-08-25 | 2014-11-19 | 唐国萍 | 一种治疗偏头疼的中药组合物及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107213170A (zh) * | 2017-06-27 | 2017-09-29 | 青川县川申农特产开发有限公司 | 一种桂花蜂蜜及制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103071128B (zh) | 一种治疗痛经的外用贴膏 | |
CN103536758B (zh) | 一种治疗阴虚盗汗的中药组合物 | |
CN104524337A (zh) | 一种治疗口腔溃疡的中药 | |
CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
CN104225215A (zh) | 一种治疗失眠的中药 | |
CN101204481A (zh) | 一种治疗慢性肾炎的中药 | |
CN104147388B (zh) | 一种治疗偏头疼的中药组合物及其制备方法 | |
CN104666658A (zh) | 一种治疗骨肉瘤骨痛及骨转移瘤骨痛的中药组方、制备方法及其应用 | |
CN106344818A (zh) | 一种用于治疗偏头痛的中药组合物的制备方法 | |
CN103638234A (zh) | 一种治疗耳鸣的中药组合物、制剂及其制备方法 | |
CN102784234A (zh) | 一种治疗慢性荨麻疹的中药组合物 | |
CN103212030B (zh) | 一种治疗肝郁型乳腺增生的中药及制备方法 | |
CN105213758A (zh) | 一种治疗慢性肺炎的中药组合物及其制备方法 | |
CN106266637A (zh) | 一种用于治疗偏头痛的中药组合物 | |
CN104547369A (zh) | 一种治疗眼睑痉挛的内服药物及其制备方法 | |
CN103520354A (zh) | 一种治疗血虚型乳腺增生的中药及制备方法 | |
CN110841007B (zh) | 一种治疗脑中风后遗症的中药组合物及其应用 | |
CN103845690A (zh) | 一种治疗老年抑郁症的药物 | |
CN103285108B (zh) | 一种治疗腰痛的中药组合物 | |
CN101897935A (zh) | 一种治疗胃柿石的中药组合物 | |
CN106266014A (zh) | 一种用于治疗心动过速的中药组合物及其制备方法 | |
CN105998738A (zh) | 一种治疗盗汗的中药组合物 | |
CN105435103A (zh) | 一种治疗脾虚痰阻型闭经溢乳综合征的中药 | |
CN101129718A (zh) | 治疗白癜风的中药制剂 | |
CN105362596A (zh) | 一种治疗肺气肿的中药及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170125 |
|
WW01 | Invention patent application withdrawn after publication |